A BCL-X-L PROTAC degrader DT2216 synergizes with KRAS(G12C) inhibitors for effectively treating KRAS(G12C)-mutated cancers.Sajid Khan,Janet Wiegand,Peiyi Zhang,Wanyi Hu,Dinesh Thummuri,Vivekananda Budamagunta,Nan Hua,Lingtao Jin,Carmen J. Allegra,Edmund S. Kopetz,Maria Zajac-Kaye,Frederic J. Kaye,Guangrong Zheng,Daohong ZhouCANCER RESEARCH(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要